Start here
I have a complicated relationship with Winlevi. We use it for hormonal acne in women who are not ready for a pill — birth control or spironolactone. It works about 50% of the time, and when it works it works; otherwise nothing at all. It is expensive and needs refrigerating, and spironolactone is far cheaper if a pill is acceptable.
— Dr. Schwarz, Board Certified Dermatologist
Key Facts
−
| Also called | Winlevi |
| Drug class | Topical androgen receptor inhibitor |
| Applied as | 1% cream |
| Typical course | Long term, while acne is active |
| Time to work | About 12 weeks |
| Prescription only | Yes |
What It Is
−
Clascoterone is a prescription cream for acne from age 12, approved in 2020. It blocks the androgen receptors male-type hormones dock onto inside the oil gland, the first topical drug to work that way. Its structure is close to spironolactone's, but it breaks down quickly once absorbed, so the effect stays local.
How It Works
−
Androgens tell oil glands to make more oil and drive some of the inflammation behind acne, which is why acne flares at puberty, around periods, and in polycystic ovary syndrome. Clascoterone blocks that receptor in the gland, so it makes less oil and less inflammation.
A hormone blocker on the skin sounds like it should affect hormones everywhere; this one is converted to an inactive form soon after absorption, so it does not. That is why men can use it without the breast tenderness and libido changes of oral anti-androgens.
Here is where Winlevi acts in the skin, and what the others do instead.
About Winlevi
Compare
Skin basics
Winlevi works upstream of the spot, on the gland itself. Less oil means fewer plugs, less for bacteria to feed on and less inflammation, which is why it changes the pattern rather than clearing one spot. A cream that blocks the hormone signal in the skin only, so it suits men and women.
Clascoterone crosses the barrier and then breaks down quickly in the skin. Getting in easily and leaving fast is the whole design: it blocks the hormone signal in the oil gland without doing anything elsewhere.
Retinoids change how the lining of the pore sheds its cells, so the plug that starts a spot stops forming in the first place. That is why they prevent spots rather than treat the ones already there, and why the first weeks can look worse before they look better.
Salicylic acid dissolves in oil, so it gets down inside the pore rather than sitting on the surface, and loosens the plug of dead skin and sebum blocking the way out.
This works on the bacteria growing in an inflamed pore. Less bacteria means less for the immune system to react to, which is what takes the redness and soreness out of a spot.
The yeast involved here lives on everyone's skin and only causes trouble when it overgrows in oil. This reduces it, which is why the flaking and itching settle and why it comes back if treatment stops for good.
Everyone carries these mites in their follicles. In some people the immune system reacts to them, and reducing their number reduces the bumps and the redness that come with them.
The outer film of dead cells and oil. It holds water in and keeps irritants out, and it is thinner than a sheet of paper. Almost every dry, itchy, stinging skin problem starts here.
The outer layer, and the only one anything in a jar reaches. It renews itself constantly: a cell made at the bottom takes about a month to reach the surface and flake off. Most of what a skincare product does, it does here.
The living layer underneath, holding the blood vessels, the nerves and the collagen. It is where lasting change happens and it is hard to reach: most of what is sold for the skin never gets this far.
What It Treats
−

Not the Best For
−


Forms
−

Strengths
−
One strength only.
Basics
−
Sample Routine
−
Here is where Winlevi sits in a day, and what goes around it. Pick what you are treating and what your skin is like, and the rest of the routine changes to suit.
What to Expect
−
What to Avoid
−
- Broken or badly irritated skin More is absorbed through broken skin.
- Covering large areas at once Same reason. Build up rather than starting everywhere on day one.
Monitoring
−
No routine blood tests in a healthy person. Monitoring is a review at about twelve weeks.
The exception is kidney or adrenal problems, or drugs that raise potassium — then a doctor may check it. People can stay on it long term; nothing accumulates, because it breaks down quickly after absorption. The recurring issue is cost and coverage, not safety.
If You Stop
−
No rebound and no taper. The oil gland responds to androgens again, and acne generally comes back over one to three months.
Cost
−
Brand only, no generic. Among the most expensive topical acne treatments, with inconsistent coverage. Prior authorization is common, and plans usually want a retinoid and benzoyl peroxide first. Savings cards exist and change often.
Ask Your Doctor
−
How It Compares
−




Myths
+
- "It is a hormone pill." It is a cream. It blocks androgen receptors in the skin, and too little reaches the bloodstream to cause the body-wide effects the tablets can.
- "Men cannot use it." Approved for males and females from age 12. The hormonal acne treatments restricted to women are the oral ones.
- "You cannot use anything else with it." Routinely used alongside benzoyl peroxide or a retinoid.
- "It makes you sun-sensitive." No, and no known food or alcohol interactions either. Other acne treatments used with it can, which is where the idea comes from.
Questions Patients Ask
+
Can men use it?
Yes. It is inactivated quickly after absorption, so it skips the breast tenderness and libido changes of oral anti-androgens.
Does it replace spironolactone?
Usually not. It is milder, for people who cannot take spironolactone or want to avoid a tablet and blood tests.
Do I need blood tests?
Not for routine use. Potassium may be checked with kidney disease or drugs that raise it.
Can I use it with tretinoin?
Yes, a common combination. Clascoterone in the morning, retinoid at night.
References
+
- Dhillon S. Clascoterone: First Approval. Drugs. 2020. — Drugs, 2020
- Piszczatoski CR, Powell J. Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years. Clinical therapeutics. 2021. — Clinical therapeutics, 2021
- Sanchez C, Keri J. Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream. Clinical, cosmetic and investigational dermatology. 2022. — Clinical, cosmetic and investigational dermatology, 2022
- Wang J, Patel P, Mineroff J, et al. Analysis of Reddit Reveals Clascoterone Questions Among People with Acne. The Journal of clinical and aesthetic dermatology. 2025. — The Journal of clinical and aesthetic dermatology, 2025
